New trends for metal complexes with anticancer activity

Hambley, 2007, Developing new metal-based therapeutics: challenges and opportunities, Dalton Trans, 4929, 10.1039/b706075k

Orvig, 1999, Medicinal inorganic chemistry: introduction, Chem Rev, 99, 2201, 10.1021/cr980419w

Guo, 1999, Metals in medicine, Angew Chem Int Ed, 38, 1512, 10.1002/(SICI)1521-3773(19990601)38:11<1512::AID-ANIE1512>3.0.CO;2-Y

Thompson, 2006, Metal complexes in medicinal chemistry: new vistas and challenges in drug design, Dalton Trans, 761, 10.1039/B513476E

Jung, 2007, Direct cellular responses to platinum-induced DNA damage, Chem Rev, 107, 1387, 10.1021/cr068207j

van Zutphen, 2005, Targeting platinum anti-tumour drugs: overview of strategies employed to reduce systemic toxicity, Coord Chem Rev, 249, 2845, 10.1016/j.ccr.2005.03.005

Yang, 2007, Encapsulation of platinum anticancer drugs by apoferritin, Chem Commun, 3453, 10.1039/b705326f

MacDiarmid, 2007, Bacterially derived 400nm particles for encapsulation and cancer cell targeting of chemotherapeutics, Cancer Cell, 11, 431, 10.1016/j.ccr.2007.03.012

Hall, 2007, Basis for design and development of platinum(IV) anticancer complexes, J Med Chem, 50, 3403, 10.1021/jm070280u

Barnes, 2004, Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes, Chem Biol, 11, 557, 10.1016/j.chembiol.2004.03.024

Ang, 2005, Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance, J Am Chem Soc, 127, 1382, 10.1021/ja0432618

Feazell, 2007, Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design, J Am Chem Soc, 129, 8438, 10.1021/ja073231f

Bednarski, 2006, Light-activated destruction of cancer cell nuclei by platinum diazide complexes, Chem Biol, 13, 61, 10.1016/j.chembiol.2005.10.011

Mackay, 2006, A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin, Chem Eur J, 12, 3155, 10.1002/chem.200501601

Heringova, 2006, Transplatin is cytotoxic when photoactivated: enhanced formation of DNA cross-links, J Med Chem, 49, 7792, 10.1021/jm0606692

Lutterman, 2006, cis-[Rh2(μ-O2CCH3)2(CH3CN)6]2+ as a photoactivated cisplatin analog, J Am Chem Soc, 128, 738, 10.1021/ja057620q

Ang, 2006, Classical and non-classical ruthenium-based anticancer drugs: Towards targeted chemotherapy, Eur J Inorg Chem, 4003, 10.1002/ejic.200600723

Liu, 2006, Diversity in guanine-selective DNA binding modes for an organometallic ruthenium arene complex, Angew Chem Int Ed, 45, 8153, 10.1002/anie.200602873

Habtemariam, 2006, Structure–activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands, J Med Chem, 49, 6858, 10.1021/jm060596m

Yan, 2005, Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes, Chem Commun, 4764, 10.1039/b508531b

Peacock, 2007, Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity, J Am Chem Soc, 129, 3348, 10.1021/ja068335p

Dyson, 2006, Metal-based antitumour drugs in the post genomic era, Dalton Trans, 1929, 10.1039/b601840h

Timerbaev, 2006, Interactions of antitumor metallodrugs with serum proteins: Advances in characterization using modern analytical methodology, Chem Rev, 106, 2224, 10.1021/cr040704h

Calderone, 2006, Structural investigation of cisplatin-protein interactions: Selective platination of His19 in a cuprozinc superoxide dismutase, Angew Chem Int Ed, 45, 1267, 10.1002/anie.200502599

McNae, 2004, Half-sandwich arene ruthenium(II)-enzyme complex, Chem Commun, 1786, 10.1039/B408141B

Casini, 2007, ESI-MS characterisation of protein adducts of anticancer ruthenium(II)–arene PTA (RAPTA) complexes, Chem Med Chem, 2, 631, 10.1002/cmdc.200600258

Weidt, 2007, Platination of superoxide dismutase with cisplatin: tracking the ammonia ligands using Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS), Chem Commun, 1719, 10.1039/b701903c

Reed, 2006, Stabilization of G-quadruplex DNA and inhibition of telomerase activity by square-planar nickel(II) complexes, J Am Chem Soc, 128, 5992, 10.1021/ja058509n

Dixon, 2007, A G-quadruplex ligand with 10000-fold selectivity over duplex DNA, J Am Chem Soc, 129, 1502, 10.1021/ja065591t

Komeda, 2006, A third mode of DNA binding: Phosphate clamps by a polynuclear platinum complex, J Am Chem Soc, 128, 16092, 10.1021/ja062851y

Harris, 2005, Synthesis, characterization, and cytotoxicity of a novel highly charged trinuclear platinum compound. Enhancement of cellular uptake with charge, Inorg Chem, 44, 9598, 10.1021/ic051390z

Oleksi, 2006, Molecular recognition of a three-way DNA junction by a metallosupramolecular helicate, Angew Chem Int Ed, 45, 1227, 10.1002/anie.200503822

Hannon, 2007, Supramolecular DNA recognition, Chem Soc Rev, 36, 280, 10.1039/B606046N

Pascu, 2007, Dinuclear ruthenium(II) triple-stranded helicates: Luminescent supramolecular cylinders that bind and coil DNA and exhibit activity against cancer cell lines, Angew Chem Int Ed, 46, 4374, 10.1002/anie.200700656

Hotze, 2006, Dinuclear double-stranded metallosupramolecular ruthenium complexes: potential anticancer drugs, Angew Chem Int Ed, 45, 4839, 10.1002/anie.200601351

Meggers, 2007, Exploring chemical space with organometallics: Ruthenium complexes as protein kinase inhibitors, Synlett, 1177, 10.1055/s-2007-973893

Bregman, 2006, Rapid access to unexplored chemical space by ligand scanning around a ruthenium center: discovery of potent and selective protein kinase inhibitors, J Am Chem Soc, 128, 877, 10.1021/ja055523r

Debreczeni, 2006, Ruthenium half-sandwich complexes bound to protein kinase Pim-1, Angew Chem Int Ed, 45, 1580, 10.1002/anie.200503468

Smalley, 2007, An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells, Cancer Res, 67, 209, 10.1158/0008-5472.CAN-06-1538

Urig, 2006, On the potential of thioredoxin reductase inhibitors for cancer therapy, Semin Cancer Biol, 16, 452, 10.1016/j.semcancer.2006.09.004

Urig, 2006, Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases, Angew Chem Int Ed, 45, 1881, 10.1002/anie.200502756

Barnard, 2007, Targeting the mitochondrial cell death pathway with gold compounds, Coord Chem Rev, 251, 1889, 10.1016/j.ccr.2007.04.006

Sun, 2007, Some uses of transition metal complexes as anti-cancer and anti-HIV agents, Dalton Trans, 4884

Wang, 2006, Proteomic characterization of the cytotoxic mechanism of gold(III) porphyrin 1a, a potential anticancer drug, Proteomics, 6, 131, 10.1002/pmic.200402027

Milacic, 2006, A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts, Cancer Res, 66, 10478, 10.1158/0008-5472.CAN-06-3017

Ott, 2005, Antitumor-active cobalt–alkyne complexes derived from acetylsalicylic acid: Studies on the mode of drug action, J Med Chem, 48, 622, 10.1021/jm049326z

Failes, 2007, Studies of a cobalt(III) complex of the MMP inhibitor marimastat: A potential hypoxia-activated prodrug, Chem Eur J, 13, 2974, 10.1002/chem.200601137

Bergamo, 2007, Ruthenium complexes can target determinants of tumour malignancy, Dalton Trans, 1267, 10.1039/b617769g

Scolaro, 2005, In vitro and in vivo evaluation of ruthenium(II)–arene PTA complexes, J Med Chem, 48, 4161, 10.1021/jm050015d

Schatzschneider, 2006, New principles in medicinal organometallic chemistry, Angew Chem Int Ed, 45, 1504, 10.1002/anie.200504604

Hillard, 2006, Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates, Angew Chem Int Ed, 45, 285, 10.1002/anie.200502925

James, 2006, Enantioselective synthesis of ferrocenyl nucleoside analogues with apoptosis-inducing activity, Org Lett, 8, 2763, 10.1021/ol060868f

Schlawe, 2004, Iron-containing nucleoside analogues with pronounced apoptosis-inducing activity, Angew Chem Int Ed, 43, 1731, 10.1002/anie.200353132

Noor, 2005, A cobaltocenium-peptide bioconjugate shows enhanced cellular uptake and directed nuclear delivery, Angew Chem Int Ed, 44, 2429, 10.1002/anie.200462519

Mackay, 2007, A potent cytotoxic photoactivated platinum complex, PNAS, 104, 20743, 10.1073/pnas.0707742105